Medicus Sciences Acquisition Corp. (NasdaqCM:MSAC) (MSAC) signed a non-binding letter of intent to acquire Anteris Technologies Ltd (ASX:AVR) on February 8, 2022. All existing Anteris shareholders will receive shares in MSAC in exchange for their shares. The proposal contemplates an issuance of new equity by MSAC in exchange for the current shares in Anteris at an equivalent value and stipulates that post-transaction the merged entity.

Medicus Sciences Acquisition Corp. (NasdaqCM:MSAC) (MSAC) cancelled the acquisition of Anteris Technologies Ltd (ASX:AVR) on February 15, 2022. Anteris Technologies Ltd declined the proposal because its Board concluded the timing of the proposal was not in shareholders nor the Company's best interest at this point.